Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is a marker of Insulin Resistance (IR). Euglycemic-hyperinsulinemic clamp is the gold standard for measuring whole body IR (hepatic + peripheral IR). However, it is an invasive and expensive procedure. Ho...

Full description

Saved in:
Bibliographic Details
Main Authors: Kamran Qureshi, Ronald H. Clements, Fahad Saeed, Gary A. Abrams
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Journal of Obesity
Online Access:http://dx.doi.org/10.1155/2010/741521
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550689143783424
author Kamran Qureshi
Ronald H. Clements
Fahad Saeed
Gary A. Abrams
author_facet Kamran Qureshi
Ronald H. Clements
Fahad Saeed
Gary A. Abrams
author_sort Kamran Qureshi
collection DOAJ
description Nonalcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is a marker of Insulin Resistance (IR). Euglycemic-hyperinsulinemic clamp is the gold standard for measuring whole body IR (hepatic + peripheral IR). However, it is an invasive and expensive procedure. Homeostasis Model Assessment Index for Insulin Sensitivity (HOMA-IS), Quantitative Insulin Sensitivity Check Index (QUICKI) for hepatic IR and Insulin Sensitivity Index (ISI0,120), and Whole Body Insulin Sensitivity Index (WBISI) for whole body IR are the indices calculated after Oral Glucose Tolerance Test (OGTT). We used these indices as noninvasive methods of IR (inverse of insulin sensitivity) estimation and compared hepatic/peripheral components of whole body IR in NAFLD. Methods. 113 morbidly obese, nondiabetic subjects who underwent gastric bypass surgery and intraoperative liver biopsy were included in the study. OGTT was performed preoperatively and the indices were calculated. Subjects were divided into closely matched groups as normal, fatty liver (FL) and Non-Alcoholic Steatohepatitis (NASH) based on histology. Results. Whole body IR was significantly higher in both FL and NASH groups (NAFLD) as compared to Normal, while hepatic IR was higher only in NASH from Normal. Conclusions. FL is a manifestation of peripheral IR but not hepatic IR.
format Article
id doaj-art-3f38eec6d7f24f16a2eefae9fdbd1aa8
institution Kabale University
issn 2090-0708
2090-0716
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Journal of Obesity
spelling doaj-art-3f38eec6d7f24f16a2eefae9fdbd1aa82025-02-03T06:06:01ZengWileyJournal of Obesity2090-07082090-07162010-01-01201010.1155/2010/741521741521Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver DiseaseKamran Qureshi0Ronald H. Clements1Fahad Saeed2Gary A. Abrams3Department of Medicine, University of Illinois at Urbana, Champaign, IL 61801, USADepartment of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294-1150, USADepartment of Medicine, University of Illinois at Urbana, Champaign, USASchool of Medicine, UAB Health Center at Montgomery, 2055 East South Blvd, Marrow Tower, Suite 806, Montgomery, AL 36116, USANonalcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is a marker of Insulin Resistance (IR). Euglycemic-hyperinsulinemic clamp is the gold standard for measuring whole body IR (hepatic + peripheral IR). However, it is an invasive and expensive procedure. Homeostasis Model Assessment Index for Insulin Sensitivity (HOMA-IS), Quantitative Insulin Sensitivity Check Index (QUICKI) for hepatic IR and Insulin Sensitivity Index (ISI0,120), and Whole Body Insulin Sensitivity Index (WBISI) for whole body IR are the indices calculated after Oral Glucose Tolerance Test (OGTT). We used these indices as noninvasive methods of IR (inverse of insulin sensitivity) estimation and compared hepatic/peripheral components of whole body IR in NAFLD. Methods. 113 morbidly obese, nondiabetic subjects who underwent gastric bypass surgery and intraoperative liver biopsy were included in the study. OGTT was performed preoperatively and the indices were calculated. Subjects were divided into closely matched groups as normal, fatty liver (FL) and Non-Alcoholic Steatohepatitis (NASH) based on histology. Results. Whole body IR was significantly higher in both FL and NASH groups (NAFLD) as compared to Normal, while hepatic IR was higher only in NASH from Normal. Conclusions. FL is a manifestation of peripheral IR but not hepatic IR.http://dx.doi.org/10.1155/2010/741521
spellingShingle Kamran Qureshi
Ronald H. Clements
Fahad Saeed
Gary A. Abrams
Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease
Journal of Obesity
title Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease
title_full Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease
title_fullStr Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease
title_full_unstemmed Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease
title_short Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease
title_sort comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic fatty liver disease
url http://dx.doi.org/10.1155/2010/741521
work_keys_str_mv AT kamranqureshi comparativeevaluationofwholebodyandhepaticinsulinresistanceusingindicesfromoralglucosetolerancetestinmorbidlyobesesubjectswithnonalcoholicfattyliverdisease
AT ronaldhclements comparativeevaluationofwholebodyandhepaticinsulinresistanceusingindicesfromoralglucosetolerancetestinmorbidlyobesesubjectswithnonalcoholicfattyliverdisease
AT fahadsaeed comparativeevaluationofwholebodyandhepaticinsulinresistanceusingindicesfromoralglucosetolerancetestinmorbidlyobesesubjectswithnonalcoholicfattyliverdisease
AT garyaabrams comparativeevaluationofwholebodyandhepaticinsulinresistanceusingindicesfromoralglucosetolerancetestinmorbidlyobesesubjectswithnonalcoholicfattyliverdisease